mesalamine 66.7 MG/ML Enema [Rowasa]
- RxCUI
- 206798
- RxNorm name
- mesalamine 66.7 MG/ML Enema [Rowasa]
- Display name
- mesalamine 66.7 MG/ML Enema [Rowasa]
- Full name
- mesalamine 66.7 MG/ML Enema [Rowasa]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:25
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rowasa | MESALAMINE | Viatris Specialty LLC | e505ab99-1943-4216-a178-4d5dbe64e3b2 | 2026-08-03 | Warnings, Adverse reactions | 206798 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e505ab99-1943-4216-a178-4d5dbe64e3b2 | sfRowasa 4 GM in 60 mL Enema [PSN] · mesalamine 66.7 MG/ML Enema [Rowasa] [SBD] · Rowasa 4 GM per 60 ML Enema [SY] · Rowasa 66.7 MG/ML Enema [SY] · sfRowasa 4 GM per 60 ML Enema [SY] | 5 | 17 | These highlights do not include all the information needed to use ROWASA safely and effectively. See full prescribing information for ROWASA . ROWASA (mesalamine) rectal suspension Initial U.S. Approval: 1987 | 20240715 |
| aa273fdc-f7c4-4901-8f71-59ae03b8cdb1 | sfRowasa 4 GM in 60 mL Enema [PSN] · mesalamine 66.7 MG/ML Enema [Rowasa] [SBD] · Rowasa 4 GM per 60 ML Enema [SY] · Rowasa 66.7 MG/ML Enema [SY] · sfRowasa 4 GM per 60 ML Enema [SY] | 5 | 12 | These highlights do not include all the information needed to use sfROWASA safely and effectively. See full prescribing information for sfROWASA. sfROWASA® (mesalamine) rectal suspension sulfite-free formulation Initial U.S. Approval: 1987 | 20240724 |